NCT02244879View on ClinicalTrials.gov

Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Type 2 Diabetes MellitusInflammationInsulin ResistanceOther Disorders of Bone Density and Structure
Interventions
DIETARY_SUPPLEMENT

resveratrol

arm resveratrol 500: 6 months of resveratrol 500 mg/day arm resveratrol 40: 6 months of resveratrol 40 mg/day

Trial Locations (1)

10126

University of Turin, Turin

All Listed Sponsors
collaborator

Ministry of Health, Italy

OTHER_GOV

lead

University of Turin, Italy

OTHER

NCT02244879 - Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter